Illumina, Inc. vs MobilEye Global Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while MobilEye Global Inc trades at $8.9 (market cap $7.54B). The key difference: Illumina, Inc. is far larger — about 3.9× MobilEye Global Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | MBLY | |
|---|---|---|
Market Cap | $29.12B | $7.54B |
Sector | Health | Technology |
52-Week High | $205.10 | $15.54 |
52-Week Low | $91.00 | $6.56 |
Enterprise Value | $30.48B | $6.10B |
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →